Boston Scientific leads $175M investment in 4C Medical

Boston Scientific led a $175 million investment in heart disease device developer 4C Medical Technologies.
The investment, which 4C Medical disclosed Wednesday, will support an ongoing pivotal trial of the company’s transcatheter mitral valve replacement device in the U.S. and Europe.
4C Medical’s focus on minimally invasive therapies for structural heart disease aligns with Boston Scientific’s activities.